Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 14/20 | 0.51 |
| ▸ | THRB | P10828 | 14/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.45 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.45 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.45 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23442253 | 0.94 | THRB (0.57) | THRATHRBCYP2C9UGT1A1ABCG2 | |
| SCHEMBL23441640 | 0.90 | THRB (0.55) | THRATHRBCYP2C9UGT1A1ABCG2 | |
| SCHEMBL23441641 | 0.90 | THRB (0.55) | THRATHRBCYP2C9UGT1A1ABCG2 | |
| SCHEMBL23420401 | 0.90 | THRB (0.54) | THRATHRBCYP2C9UGT1A1ABCG2 | |
| SCHEMBL23442829 | 0.85 | THRB (0.69) | THRATHRBCYP2C9UGT1A1ABCG2 | |
| SCHEMBL23441637 | 0.81 | THRB (0.67) | THRATHRBCYP2C9UGT1A1ABCG2 | |
| SCHEMBL23441633 | 0.81 | THRB (0.67) | THRATHRBCYP2C9UGT1A1ABCG2 | |
| SCHEMBL23441645 | 0.81 | THRB (0.66) | THRATHRBCYP2C9UGT1A1ABCG2 | |
| SCHEMBL24032555 | 0.80 | THRA (0.55) | THRATHRBCYP2C9UGT1A1ABCG2 | |
| SCHEMBL23442834 | 0.78 | THRA (0.69) | THRATHRBCYP2C9UGT1A1ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021104288-A1 | 1,2,4-TRIAZINE-3,5-DIONE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 昆药集团股份有限公司 | 2021-06-03 | — | — | WO | disclosed |